STAT+: BridgeBio Drug for Genetic Cause of Dwarfism Succeeds in Key Study
BridgeBio Pharma's oral drug infigratinib met its primary endpoint in a pivotal trial of more than 100 children with achondroplasia, delivering an average growth increase of 2.1 cm per year versus placebo. Adjusted analysis showed a 1.74 cm per year advantage, both statistically significant. The efficacy exceeds that of BioMarin's approved injectable, which added 1.57 cm per year in its own study. Results clear a regulatory path for the first oral therapy targeting the most common genetic form of dwarfism.
7 Million Cancers A Year Are Preventable, Says New Report
A new WHO‑backed study in Nature Medicine estimates that 7 million cancer cases each year—about 37 % of the global burden—are preventable. Tobacco, infections and alcohol together account for roughly 25 % of all cancers, with tobacco alone responsible for 3.3 million cases. The...
Rethinking Employer Coverage for High-Cost Medications
Employers face a projected 9% rise in health‑benefit costs for 2026, driven largely by soaring prescription drug expenses. GLP‑1 receptor agonists, originally diabetes treatments now popular for weight loss, have become the fastest‑growing cost component, with 79% of employers reporting...
Chronic Rhinitis Solution NEUROMARK Secures €62.5 Million as Irish Startup Neurent Medical Closes Series C
Neurent Medical announced an oversubscribed €62.5 million Series C round, led by MVM Partners and Sofinnova Partners, to accelerate the commercial rollout of its NEUROMARK system for chronic rhinitis. The funding will expand European market presence, deepen clinical evidence, and support a...
New Method Can Find Hidden Eggs to Aid in Fertility Treatment
Researchers at AutoIVF introduced OvaReady, a microfluidic device that scans discarded follicular fluid and retrieves eggs missed by traditional microscopy. In a study of 582 patients across four U.S. clinics, the system found additional viable eggs in 316 cases, yielding...
Louisville Found PFAS in Drinking Water. The Trump Administration Wouldn’t Require Any Action.
Louisville Water discovered a sharp increase in the GenX PFAS variant in December 2024, with concentrations 15 times higher than the previous month, reaching 52 parts per trillion. The spike was traced upstream to Chemours' plant in West Virginia, but...
CBO: Medicaid Spending Increases Will Slow Due To OBBBA But Expected To Continue
The Congressional Budget Office (CBO) projects that the 2025 reconciliation bill’s Omnibus Budget Reconciliation Act (OBBBA) will trim roughly $1.2 trillion from Medicaid spending over the next decade. Despite this sizable reduction, overall Medicaid outlays are expected to keep rising because...
E&C Health Panel Determined To Rein In Remaining PBM Business Tactics
On February 11, the House Energy & Commerce health subcommittee signaled it will keep pressuring pharmacy benefit managers (PBMs) after a recent FTC settlement involving Cigna’s Express Scripts. Chair Rep. Buddy Carter asked the new head of the traditional PBM...
The 2026 PM360 Pharma Choice Awards – Variety BRONZE Winner
The 2026 PM360 Pharma Choice Awards named Fingerpaint Multicultural and Novo Nordisk’s "Maneja Tu Peso" campaign a Variety Bronze winner. The initiative is an online hub aimed at US Hispanic adults living with obesity, delivering culturally tailored education and a...
Proposed CMS Rule Upholds Exclusion of Nursing Home Custodial Care From Essential Benefits
CMS issued a Notice of Benefit and Payment Parameters for 2027 proposing to keep long‑term nursing‑home custodial care outside the list of essential health benefits required for ACA marketplace plans. The rule maintains that custodial stays are not mandatory coverage,...
Coast-to-Coast Hospice Growth as Facilities Proliferate
Hospice providers are expanding coast‑to‑coast, with Augusta Inpatient Hospice Home opening in Georgia, Julia Hospice & Palliative Care planning a nine‑room Julia House in Pennsylvania, and Tri‑Cities Chaplaincy completing a $3.5 million renovation in Washington. In Florida, Gulfside Healthcare Services broadened...
Maine Hospital Association President Michaud to Retire; Jeffrey Austin Named Successor
The Maine Hospital Association announced that long‑time President Steven Michaud will retire after a 27‑year tenure, having led the organization since 1999. Jeffrey Austin, currently vice president of government affairs and communications, will take over as president on March 1, 2026....
Senate Aging Committee Holds Hearing on Physician Burnout
The Senate Special Committee on Aging convened a hearing on Feb. 11 to address the growing physician burnout crisis. The American Hospital Association (AHA) urged Congress to act on three bills: the Improving Seniors’ Timely Access to Care Act to simplify...
House Subcommittee Hearing Discusses Impacts of Drug Pricing on Health Care Costs
The House Energy and Commerce Subcommittee on Health held a hearing on Feb. 11 to examine how prescription‑drug pricing affects overall health‑care costs. The American Hospital Association (AHA) testified, warning that proposals to replace the 340B drug‑pricing program with a rebate...
OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke
The randomized OPTION trial showed that intravenous tenecteplase given 4.5 to 24 hours after symptom onset improves functional outcomes in patients with acute non‑large‑vessel‑occlusion (non‑LVO) strokes. At 90 days, 43.6% of tenecteplase recipients achieved a modified Rankin Scale score of...
Sober-Curious? Here’s A Timeline Of What Happens When You Quit Alcohol
The sober‑curious movement is reshaping how Americans view alcohol, with celebrity disclosures and a Gallup poll showing drinking prevalence falling to 54 % of adults. Scientific research now outlines a clear health‑recovery timeline: blood pressure drops in the first week, insulin...
Landers Exits As Alliance CEO, Sheets Takes Helm
Dr. Steve Landers stepped down as CEO of the National Alliance for Care at Home, ending his 17‑month tenure that began in September 2024. He will remain on the board to aid the transition, which takes effect on Feb. 9. Jennifer...
Anti-Epileptic Drug May Prevent Early Plaque Formation in Alzheimer’s Disease
Scientists at Northwestern University identified that the toxic amyloid‑beta 42 peptide accumulates inside neuronal synaptic vesicles and that the FDA‑approved anti‑epileptic drug levetiracetam can halt this process. By binding to the SV2A protein, levetiracetam alters APP trafficking, keeping the precursor...
Streamlining Research Antibody and Reagent Selection
CiteAb unveiled the Explore Platform, combining its long‑standing reagent search engine with a new image‑search capability. The platform draws on a database of more than 16 million research tools cited in over 40 million publications, spanning antibodies, proteins, models and kits. Its...
Lubrizol Launches Tolerathane TPU for Implantable Medical Devices
Lubrizol has launched Tolerathane™ TPU, a medical‑grade thermoplastic polyurethane designed for implantable devices. The material offers superior resistance to oxidative and hydrolytic degradation while maintaining exceptional softness and mechanical resilience. It integrates with standard thermal processing, enabling thinner‑wall, miniaturized designs...
How the Largest Health-Care Education Company in U.S. Is Addressing a Growing Jobs Gap
Covista, the former Adtalem Global Education, has rebranded to signal its exclusive focus on health‑care education amid a widening U.S. workforce gap. The company reports more than 24,000 health‑care graduates each year, accounting for roughly 10% of the nation’s nurses...
Review: Box Facilitates Secure Collaboration for Healthcare Workers
Box Intelligent Content Management delivers a cloud‑based, zero‑trust platform tailored for healthcare’s strict security and compliance needs. The solution unifies over 1,500 integrations, enabling seamless collaboration between Office 365, Google Workspace and other systems while providing built‑in e‑signatures and workflow automation....
Novo Nordisk CEO Sees 15 Million Patient Opportunity in Medicare Coverage for Obesity Drugs
Novo Nordisk CEO Mike Doustdar said the firm aims to capture roughly 15 million new patients once Medicare begins covering obesity drugs later this year. The coverage, part of a "most‑favored‑nation" pricing deal with the Trump administration, could expand the market...
EAPCI Summit 2026: What to Expect in Munich
The inaugural European Association of Percutaneous Cardiovascular Interventions (EAPCI) Summit will take place in Munich on February 19‑20, 2026, offering a two‑day program of technical deep dives, AI-focused sessions, and hands‑on training. Over 300 abstracts and clinical cases will be...
Mayo Clinic Platform Standardizes Cancer Data to Speed Up Trials
Mayo Clinic Platform’s Orchestrate tool has added new capabilities that deliver standardized, research‑ready cancer data. The upgrade leverages the OMOP Oncology common data model to transform unstructured inputs such as pathology reports and imaging into consistent tumor characteristics, biomarkers, and...
Zimmer Plans US Salesforce Reorganization
Zimmer Biomet announced a U.S. salesforce reorganization aimed at creating a fully dedicated, product‑specialized team of 2,500 reps. The shift targets high‑growth segments such as sports medicine, trauma, robotics, and ambulatory surgery centers, with one‑third of the transition already complete....
WTWH Healthcare Is Now Accepting Nominations For the 2026 Memory Care Innovation Awards
WTWH Healthcare has opened nominations for its 2026 Memory Care Innovation Awards, honoring individuals and organizations that advance cognitive care across home health, hospice, senior living, and related sectors. Eligible nominees must have at least seven years of experience and...
Why Harbor Health Is Acquiring Dementia Support Company Rippl
Harbor Health, an Austin‑based primary care and health‑insurance group, announced the acquisition of Rippl, a Seattle‑based dementia‑care platform. The deal, terms undisclosed, adds Rippl’s CMS GUIDE‑model services for Medicare Advantage and traditional Medicare beneficiaries to Harbor’s condition‑focused care pathways. By...
Pediatric Palliative Care Policy Framework: Overhaul Medicaid
A new national policy framework released by Children’s Respite Homes of America and the National Center for Pediatric Palliative Care Homes proposes mandatory Medicaid EPSDT coverage for community‑based pediatric palliative care centers (PPCCenters) and short‑term respite (PPCRespite). The paper defines...
Take2 Raises $14M Series A for AI Hiring
Take2 announced a $14 million Series A round led by Human Capital, with participation from Bertelsmann Healthcare Investments, Reach Capital, SemperVirens VC and Honeystone Ventures. The startup builds autonomous AI agents that conduct phone interviews, schedule appointments and handle credential verification for...
Study Explores Most Cost-Effective Smoking Cessation Methods in Lung Cancer Screening
A recent economic evaluation of the ASSIST trial at Massachusetts General Hospital identified the most cost‑effective smoking‑cessation approach for patients undergoing lung‑cancer screening. The optimal strategy combined eight telehealth counseling sessions with a two‑week course of nicotine‑replacement patches, achieving an...
Federal Telehealth Policy in 2026: What the Medicare Extensions Mean
Congress approved the Consolidated Appropriations Act of 2026, extending key Medicare telehealth flexibilities through Dec. 31 2027. The extension preserves waivers for in‑person visits, home‑based originating sites, audio‑only services, and broader clinician eligibility, while renewing the Acute Hospital at Home program to...
STS Spells Out Training Pathway for Robotic Surgery
The Society of Thoracic Surgeons (STS) unveiled a five‑phase training pathway to standardize robotic cardiac surgery adoption, covering prerequisites, baseline team training, initial clinical use, efficiency gains, and mastery. The guideline mandates at least three years of attending experience or...
Both Low-Fat and Low-Carb Diets Tied to Less Heart Disease
A large prospective analysis of three U.S. cohorts found that both low‑carbohydrate and low‑fat eating patterns can reduce coronary heart disease risk when they emphasize nutrient‑dense, plant‑based foods. In contrast, versions of these diets high in animal fat, animal protein,...
Women Show Greater Dementia Risk Reduction From Shingles Vaccine
A retrospective cohort study of Kaiser Permanente members aged 65 and older found that receiving two doses of the recombinant zoster vaccine (Shingrix) was associated with a 51% lower incidence of dementia. The protective effect was observed across age, racial,...
ACE Inhibitors Linked to Reduced Mortality in Idiopathic Pulmonary Fibrosis
A large UK observational study published in Chest found that angiotensin‑converting enzyme (ACE) inhibitor use is linked to an 18 % relative reduction in all‑cause mortality among idiopathic pulmonary fibrosis (IPF) patients, with a hazard ratio of 0.82. The analysis covered...
NIH Researchers Identify Four-Marker Blood Test That May Improve Early Pancreatic Cancer Detection
NIH‑backed researchers reported a four‑marker blood test that improves early detection of pancreatic ductal adenocarcinoma. The panel combines CA19‑9, THBS2, ANPEP and PIGR, achieving 91.9% overall accuracy at a 5% false‑positive rate and 87.5% sensitivity for stage I‑II disease. The study...
New Medicaid Work Rules Likely To Hit Middle-Aged Adults Hard
Starting in January, new Medicaid work requirements will compel about 20 million low‑income adults in 42 states to log at least 80 hours of work, volunteering, or schooling each month to retain coverage. The rules disproportionately affect middle‑aged adults, especially women...
End of Enhanced Obamacare Subsidies Puts Tribal Health Lifeline at Risk
Tribal health‑insurance programs that rely on ACA premium subsidies are facing a funding crisis after the enhanced tax credits expired at the end of 2025. Premiums have surged, forcing tribes like Fort Peck and Blackfeet to limit enrollment and risk...
BioRestorative Concludes Phase II BRTX-100 Trial Enrolment for cLDD
BioRestorative Therapies announced completion of patient enrollment for its Phase II BRTX‑100 trial in chronic lumbar disc disease, enrolling 99 subjects at 15 U.S. sites. The double‑blind, sham‑controlled study randomizes participants 2:1 to receive an autologous hypoxically cultured mesenchymal stem cell...
Eight Biotech Companies Spearheading the Antibody Drug Conjugate New Wave
A new wave of eight biotech firms is redefining antibody‑drug conjugates (ADCs) by pursuing unconventional targets, advanced linker chemistries, and novel cytotoxic payloads. Companies such as Adcendo, Adcentrx, and Tubulis are advancing phase 1/2 programs that address sarcoma, Nectin‑4, NaPi2b, and...
Avoiding ‘Stacking’ Consequences: Top Home-Based Care Employment Law Considerations
Home‑based care providers are confronting a fragmented employment‑law landscape, prompting a Polsinelli webinar that outlines urgent compliance steps. Within the next three to six months firms should audit wage, leave and worker classification, verify salary‑range postings, and evaluate AI‑driven recruiting...
Amazon One Medical Introduces Health Insights to Help Patients Better Understand Their Lab Results
Amazon One Medical launched Health Insights, a beta tool that converts routine bloodwork into personalized health information. Developed with Lifeforce, the feature evaluates over 50 biomarkers and delivers a wellness score, domain‑specific analysis, and evidence‑based lifestyle recommendations at no extra...
3-Day Hospital Stay Rule for Nursing Homes Fails to Improve Outcomes, Cut Costs, as Researchers Question ‘Rigid’ Thresholds
A JAMA Internal Medicine cohort study of more than 600,000 Medicare hospitalizations found that reinstating the three‑day inpatient rule lengthened stays but did not curb skilled nursing facility (SNF) discharges, improve 30‑day outcomes, or lower Medicare spending. The rule increased...
Dr. Oz Says Drinking Is a ‘Social Lubricant.’ Some Experts Worry About That.
Dr. Mehmet Oz described alcohol as a “social lubricant” while the U.S. dietary guidelines were revised to eliminate the traditional one‑drink‑for‑women, two‑drinks‑for‑men cap. The updated recommendations now only advise Americans to drink “less,” despite evidence that even low‑level consumption raises cancer...
CMS Proposes 2027 ACA Marketplace Changes to Address Rising Premiums
CMS released a proposed rule for the 2027 ACA marketplaces aimed at curbing rising premiums and stabilizing enrollment after enhanced subsidies expired in 2026. The rule would allow non‑network plans to sell on the exchanges, extend catastrophic coverage terms up...
A Conversation About Nighttime Itch with Gil Yosipovitch, M.D., Dermatology Professor at Miller School of Medicine at the University of...
Researchers at the Miami Itch Center, led by Dr. Gil Yosipovitch, found that nocturnal pruritus spikes due to circadian shifts in cytokines, increased skin permeability, and a modest rise in skin temperature. The study links chronic itch to chronic pain,...
New Grants Fuel Psychedelic End-of-Life, Palliative Care Innovation
Healing Hearts Changing Minds (HHCM) announced a $566,260 grant program called Walking Each Other Home, supporting seven hospice, palliative and psychedelic care organizations across the United States. The funding will enable clinical trials of psilocybin for brain‑tumor patients, ketamine‑assisted psychotherapy...
MDMOM: Innovating Around Maternal Health in Maryland
The Maryland Maternal Health Innovation Program (MDMOM), funded with $15.8 million from HRSA, is coordinating data, quality improvement, workforce development, and community engagement across all 32 birthing hospitals in the state. Led by Dr. Andreea Creanga, the initiative has instituted statewide...
AdvaMed Names New EVP of Technology and Regulatory Affairs
AdvaMed announced Melissa Torres as its new executive vice president of technology and regulatory affairs, succeeding long‑time leader Janet Trunzo. Torres arrives with more than two decades of FDA leadership, most recently as associate director for international affairs at CDRH....